We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

From regional organizations to local centers, there are many ways to donate badly needed blood samples to Delawareans in 2025 ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

Immune complexes, like the inflammasome, help protect stem cells from cancer by removing surface receptors and suppressing ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

Investing.com -- AstraZeneca (LON: AZN) in a stock exchange filing on Friday said that the FDA approved its drug Calquence ...

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH ... chimeric antigen receptor T-cell therapy vs standard treatments for patients with multiple ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients ...

As humans age, we develop chronic inflammation in our blood and tissues that gradually decreases the function of blood stem ...

Indore (Madhya Pradesh): The Super Specialty Hospital (SSH) administration here has claimed to have achieved a medical ...

Beam’s wave 1 approach is BEAM-101, an autologous investigational cell therapy designed to efficiently and uniformly increase fetal hemoglobin (HbF) in red blood cells without relying on double ...